|
|
|
Volumn 11, Issue , 2003, Pages 23-31
|
|
Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOKINE;
ANIMAL;
ARTIFICIAL SKIN;
CELL CULTURE;
CLINICAL TRIAL;
DIABETIC FOOT;
DISEASE MODEL;
FIBROBLAST;
GRAFT SURVIVAL;
HOSPITALIZATION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
METABOLISM;
METHODOLOGY;
MOLECULAR GENETICS;
MOUSE;
NEEDLE BIOPSY;
NUCLEOTIDE SEQUENCE;
PATHOLOGY;
PHYSIOLOGY;
POLYMERASE CHAIN REACTION;
REVIEW;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SKIN TRANSPLANTATION;
TRANSPLANTATION;
TREATMENT OUTCOME;
WOUND HEALING;
ANIMALS;
BASE SEQUENCE;
BIOPSY, NEEDLE;
CELLS, CULTURED;
CLINICAL TRIALS;
CYTOKINES;
DIABETIC FOOT;
DISEASE MODELS, ANIMAL;
FIBROBLASTS;
GRAFT SURVIVAL;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MICE;
MOLECULAR SEQUENCE DATA;
POLYMERASE CHAIN REACTION;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
SKIN TRANSPLANTATION;
SKIN, ARTIFICIAL;
TISSUE AND ORGAN HARVESTING;
TREATMENT OUTCOME;
WOUND HEALING;
|
|
EID: 2442577232
PISSN: 10903941
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (62)
|
|
References (39)
|
